SAN FRANCISCO--(BUSINESS WIRE)--The Scleroderma Research Foundation (SRF), the nation’s largest non-profit funder of scleroderma research, today announced that Sanofi will contribute the first ...

CARLSBAD, California — In 2003, researchers asked 303 patients with systemic sclerosis (scleroderma) what bothered them most about their disease from an aesthetic standpoint: Orofacial features, such ...

Included patients from the Johns Hopkins Scleroderma Center Research Registry and the University of Pittsburgh Scleroderma Center, Pittsburgh, Pennsylvania. A total of 676 patients with scleroderma ...

Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune ...

Please provide your email address to receive an email when new articles are posted on . BLR-200 has yielded “promising” results in ongoing research. The therapy targets multiple drivers of scleroderma ...

Extracellular vesicles, responsible for cell-to-cell communication, might be a driver of fibrosis in systemic sclerosis, according to a recent paper in Arthritis and Rheumatology. Characterized by ...

The 2023 “Cool Comedy Hot Cuisine” fundraiser for the Scleroderma Research Foundation was filled with tributes to the late comedian and scleroderma research advocate Bob Saget, who died in 2022. Held ...

Treatment for autoimmune diseases such as systemic lupus erythematosus (SLE), idiopathic inflammatory myositis, and systemic sclerosis often involves long-term immune suppression. Resetting aberrant ...

Scleroderma is a rare autoimmune condition in which the regulation and deposition of collagen is impaired, causing inflammation and fibrosis (thickening and scarring of connective tissue) throughout ...

Scleroderma on the face can cause symptoms that may affect your appearance, including the texture, discoloration, and elasticity of your skin. Medications, facial exercises, and dermatological ...